Evidence map›Paper›PMID 41341001›Full record

Article3D printing and additive manufacturing2025

Enhancing Biocompatibility: 3D-Printed Cyclic Olefin Copolymer Structures for Advanced Laboratory Applications.

Simon Höving, Stefanie Dörr, Marc Akermann, Arthur Schiller, Kristina Lorenz, Daniel Schwendemann, Joachim Franzke, Sebastian Brandt

Abstract read
In one paragraph

Article in 3D printing and additive manufacturing, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Simon HövingTranslationale Forschung, Miniaturisierung, Leibniz-Institut für Analytische Wissenschaften - ISAS e.V., Dortmund, Germany.ORCID https://orcid.org/0000-0001-5606-3615
Stefanie DörrTranslationale Forschung, Miniaturisierung, Leibniz-Institut für Analytische Wissenschaften - ISAS e.V., Dortmund, Germany.
Marc AkermannCompoundierung/Extrusion, Institut für Werkstofftechnik und Kunststoffbearbeitung, OST - Ostschweizer Fachhochschule, Rapperswil, Switzerland.ORCID https://orcid.org/0000-0002-8327-4159
Arthur SchillerTranslationale Forschung, Miniaturisierung, Leibniz-Institut für Analytische Wissenschaften - ISAS e.V., Dortmund, Germany.ORCID https://orcid.org/0000-0001-5406-1579
Kristina LorenzTranslationale Forschung, Miniaturisierung, Leibniz-Institut für Analytische Wissenschaften - ISAS e.V., Dortmund, Germany.ORCID https://orcid.org/0000-0002-5747-2207
Daniel SchwendemannCompoundierung/Extrusion, Institut für Werkstofftechnik und Kunststoffbearbeitung, OST - Ostschweizer Fachhochschule, Rapperswil, Switzerland.ORCID https://orcid.org/0000-0003-0607-2059
Joachim FranzkeTranslationale Forschung, Miniaturisierung, Leibniz-Institut für Analytische Wissenschaften - ISAS e.V., Dortmund, Germany.ORCID https://orcid.org/0000-0003-0419-1898
Sebastian BrandtTranslationale Forschung, Miniaturisierung, Leibniz-Institut für Analytische Wissenschaften - ISAS e.V., Dortmund, Germany.ORCID https://orcid.org/0000-0002-6938-3033

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Additive manufacturing, particularly 3D-printing, has emerged as a crucial method for creating prototypes and specialized components in various scientific fields. This study investigates the biocompatibility and performance of 3D-printed materials, with focus on cyclic olefin copolymer (COC) in comparison with traditional materials such as polylactic acid (PLA) and COC combined with glass (Glass + COC) inlays. Biocompatibility is especially critical for cell-based research and millifluidic applications, impacting cell culture experiments and the interaction of 3D-printed structures with reactive substances. To investigate material influence, experiments were conducted using rat cardiomyocyte (H9c2) and human embryonal kidney (HEK293) cell lines, with comprehensive assays including lactate, lactate dehydrogenase (LDH), and thiazolyl blue tetrazolium bromide assays assessing metabolic activity, cell stress, and cell viability. Results demonstrated that Glass + COC exhibited increased metabolic activity and cell viability compared with standard polystyrene (PS) culture dishes, with COC and PLA materials showing comparable viability with standard PS dishes, although with slight differences favoring COC. Lactate assays revealed subtle increases in lactate secretion, notably in Glass + COC cultures, suggesting a correlation with cell viability. LDH assays provided insights into potential material-associated toxicity. Microscopy experiments visually confirmed cell growth and distribution within culture vials, using various transparent materials, including PLA foil, COC foil, standard microscope glass slides, and Glass + COC. Furthermore, atomic force microscopy (AFM) examined surface roughness and differences between the upper and lower surfaces of 3D-printed PLA and COC parts, contributing to the understanding of material surface characteristics. In conclusion, this study highlights the biocompatibility of 3D-printed materials for cell-based research, emphasizing the potential of COC and Glass + COC manufactured via 3D-printing for such applications. The interplay among cell viability, metabolic activity, and lactate levels underscores the importance of material selection. Microscopy and AFM analyses enhance the comprehension of cell growth behavior and surface properties, advancing the selection of 3D-printed materials for biocompatible applications.

Indexed as

additive manufacturingbiocompatibilitycell viabilitycyclic olefin copolymer (COC)extrusion 3D-printinglaboratory applications

Identifiers

PMID41341001
PMCPMC12670670

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.